Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
Article Abstract:
The sensitivity of conventional DNA sequencing in tumor biopsies is limited by stromal contamination and genetic heterogeneity within the cancer. Studies show that microreactor-based pyrosequencing can detect rare cancer-associated sequence variations by independent and parallel sampling of multiple representatives of a given DNA fragment. This technology can thereby facilitate accurate molecular diagnosis of heterogeneous cancer specimens and enable patient selection for targeted cancer therapies.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Cancer researchers usher in dog days of medicine
Article Abstract:
Researchers at the US National Cancer Institute are set to begin drug trials in dogs that aim to bridge the gap between preclinical drug studies and effects of the same drug in people as part of a new comparative-oncology program. Two multicenter trials, set to begin in early 2006 would evaluate new therapeutic approaches for cancer in dogs.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Studying cancer families to identify kidney cancer genes
- Abstracts: Using an interactive video disk in breast cancer patient support. Meeting the needs of younger women with breast cancer
- Abstracts: Hemoglobin variants and disease manifestations in severe Falciparum malaria. Autism intervention comes of age
- Abstracts: Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Pleomorphic rhabdomyosarcoma of the anterior abdominal wall following multimodality treatment for carcinoma of the rectum
- Abstracts: Male hormonal contraception. Newborn screening-should it be part of prenatal care?